FI84023C - Foerfarande foer framstaellning av en stabil farmaceutisk doseringsform, vilken laempar sig foer oral administration av etoposid. - Google Patents

Foerfarande foer framstaellning av en stabil farmaceutisk doseringsform, vilken laempar sig foer oral administration av etoposid. Download PDF

Info

Publication number
FI84023C
FI84023C FI851040A FI851040A FI84023C FI 84023 C FI84023 C FI 84023C FI 851040 A FI851040 A FI 851040A FI 851040 A FI851040 A FI 851040A FI 84023 C FI84023 C FI 84023C
Authority
FI
Finland
Prior art keywords
weight
etoposide
water
parts
acid
Prior art date
Application number
FI851040A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI851040A0 (fi
FI851040L (fi
FI84023B (fi
Inventor
Selima Begum
Ismat Ullah
Bernard C Nunning
Original Assignee
Squibb Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb Bristol Myers Co filed Critical Squibb Bristol Myers Co
Publication of FI851040A0 publication Critical patent/FI851040A0/fi
Publication of FI851040L publication Critical patent/FI851040L/fi
Application granted granted Critical
Publication of FI84023B publication Critical patent/FI84023B/fi
Publication of FI84023C publication Critical patent/FI84023C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
FI851040A 1984-03-19 1985-03-15 Foerfarande foer framstaellning av en stabil farmaceutisk doseringsform, vilken laempar sig foer oral administration av etoposid. FI84023C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59114484A 1984-03-19 1984-03-19
US59114484 1984-03-19

Publications (4)

Publication Number Publication Date
FI851040A0 FI851040A0 (fi) 1985-03-15
FI851040L FI851040L (fi) 1985-09-20
FI84023B FI84023B (fi) 1991-06-28
FI84023C true FI84023C (fi) 1991-10-10

Family

ID=24365235

Family Applications (1)

Application Number Title Priority Date Filing Date
FI851040A FI84023C (fi) 1984-03-19 1985-03-15 Foerfarande foer framstaellning av en stabil farmaceutisk doseringsform, vilken laempar sig foer oral administration av etoposid.

Country Status (28)

Country Link
JP (1) JPS60209516A (en, 2012)
KR (1) KR850006136A (en, 2012)
AT (1) AT392904B (en, 2012)
AU (1) AU571308B2 (en, 2012)
BE (1) BE901963A (en, 2012)
CA (1) CA1238578A (en, 2012)
CH (1) CH662731A5 (en, 2012)
DE (1) DE3509741A1 (en, 2012)
DK (1) DK164535C (en, 2012)
EG (1) EG17521A (en, 2012)
ES (1) ES8702140A1 (en, 2012)
FI (1) FI84023C (en, 2012)
FR (1) FR2561104B1 (en, 2012)
GB (1) GB2155789B (en, 2012)
GR (1) GR850688B (en, 2012)
IE (1) IE58340B1 (en, 2012)
IL (1) IL74615A (en, 2012)
IT (1) IT1187640B (en, 2012)
LU (1) LU85812A1 (en, 2012)
MY (1) MY101916A (en, 2012)
NL (1) NL8500739A (en, 2012)
NO (1) NO170569C (en, 2012)
NZ (1) NZ211078A (en, 2012)
OA (1) OA07968A (en, 2012)
PT (1) PT80131B (en, 2012)
SE (1) SE8501312L (en, 2012)
YU (1) YU45243B (en, 2012)
ZA (1) ZA851935B (en, 2012)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60239418A (ja) * 1984-05-15 1985-11-28 Nippon Kayaku Co Ltd エトポシド軟カプセル製剤
JPS61189230A (ja) * 1985-02-19 1986-08-22 Nippon Kayaku Co Ltd エトポシド製剤
DE3629386A1 (de) * 1986-08-29 1988-03-03 Scherer Gmbh R P Gelatinekapseln und verfahren zu ihrer herstellung
US4927638A (en) * 1986-10-08 1990-05-22 Bristol-Myers Company Etoposide solutions
US5154930A (en) * 1987-03-05 1992-10-13 The Liposome Company, Inc. Pharmacological agent-lipid solution preparation
US5376381A (en) * 1988-02-25 1994-12-27 The Liposome Company, Inc. Integrity protected gelatin
JP2000247911A (ja) * 1999-02-26 2000-09-12 Hisamitsu Pharmaceut Co Inc 大腸用吸収促進剤

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH580255A5 (en, 2012) * 1974-06-04 1976-09-30 Calinter Sa
DE2452785A1 (de) * 1974-11-07 1976-05-13 Universal Oil Prod Co Verfahren zum betrieb einer verbrennungsmaschine
FR2358144A1 (fr) * 1976-07-13 1978-02-10 Lipha Nouvelle composition medicamenteuse pour le traitement de la lithiase biliaire
JPS5940137B2 (ja) * 1976-10-14 1984-09-28 武田薬品工業株式会社 経口投与用医薬組成物
FR2410504A1 (fr) * 1977-12-05 1979-06-29 Air Liquide Procede de reglage de securite d'un reacteur chimique et installation de reaction d'oxydation mettant en oeuvre ce procede
DE2809543A1 (de) * 1978-03-06 1979-09-13 Werner Henke Verfahren und vorrichtung zum neutralisieren von gasen bei oel- und gasbohrungen
JPS60239418A (ja) * 1984-05-15 1985-11-28 Nippon Kayaku Co Ltd エトポシド軟カプセル製剤

Also Published As

Publication number Publication date
OA07968A (fr) 1987-01-31
SE8501312L (sv) 1985-09-20
AT392904B (de) 1991-07-10
FI851040A0 (fi) 1985-03-15
IT8519897A0 (it) 1985-03-14
LU85812A1 (fr) 1985-12-12
FR2561104B1 (fr) 1988-04-08
NZ211078A (en) 1987-08-31
GB2155789B (en) 1987-10-21
FI851040L (fi) 1985-09-20
ES8702140A1 (es) 1986-12-16
PT80131A (en) 1985-04-01
AU3897585A (en) 1985-09-26
KR850006136A (ko) 1985-10-02
BE901963A (fr) 1985-09-18
FR2561104A1 (fr) 1985-09-20
IL74615A (en) 1988-07-31
GB8506943D0 (en) 1985-04-24
ES541370A0 (es) 1986-12-16
PT80131B (pt) 1987-10-20
GR850688B (en, 2012) 1985-07-08
AU571308B2 (en) 1988-04-14
DK122285D0 (da) 1985-03-18
CA1238578A (en) 1988-06-28
NO170569B (no) 1992-07-27
EG17521A (en) 1990-06-30
IT1187640B (it) 1987-12-23
GB2155789A (en) 1985-10-02
DK164535C (da) 1992-11-30
IE850686L (en) 1985-09-19
IL74615A0 (en) 1985-06-30
IE58340B1 (en) 1993-09-08
ATA81985A (de) 1990-12-15
NO170569C (no) 1992-11-04
MY101916A (en) 1992-02-15
YU45243B (en) 1992-05-28
DE3509741A1 (de) 1985-09-26
YU42085A (en) 1988-02-29
ZA851935B (en) 1985-10-30
DK122285A (da) 1985-09-20
DK164535B (da) 1992-07-13
JPS60209516A (ja) 1985-10-22
NO851022L (no) 1985-09-20
SE8501312D0 (sv) 1985-03-18
FI84023B (fi) 1991-06-28
CH662731A5 (de) 1987-10-30
NL8500739A (nl) 1985-10-16

Similar Documents

Publication Publication Date Title
US4713246A (en) Etoposide oral dosage form
KR920003332B1 (ko) 에토포시드(Etoposide)제제의 제조방법
US5505961A (en) Gelatin capsules containing a highly concentrated acetaminophen solution
CN104857517B (zh) 一种恩杂鲁胺软胶囊及其制备方法
US3282789A (en) Stable liquid colloidal tannate compositions
FI84023C (fi) Foerfarande foer framstaellning av en stabil farmaceutisk doseringsform, vilken laempar sig foer oral administration av etoposid.
EP0359184B1 (en) Etoposide solutions
CN105688220A (zh) 一种含丁苯酞与新型增溶剂的药物组合物
CN106243180B (zh) 炔雌醇新晶型
US20030215524A1 (en) Stable pharmaceutical composition useful for treating gastrointestinal disorders
CN111643451B (zh) 一种注射用和厚朴酚自乳化微乳制剂及其制备方法
CN113679664B (zh) 白藜芦醇高分子水溶液及其制备方法
US3966949A (en) Pharmaceutical compositions and preparing same
CN106176769A (zh) 兽用长效土霉素注射液及其制备方法
US3733410A (en) Elixirs with acid addition salts of therapeutically active organic bases as active substances
KR900000513B1 (ko) 에토포사이드 경구 투여용 조성물의 제조방법
CN101953785A (zh) 杨梅素微乳类制剂及其制备方法
CN103735555A (zh) 一种葫芦素药物组合物及其制药用途
US3140233A (en) Tasteless pharmaceutical composition and process
KR100201907B1 (ko) 비페닐디메틸디카르복실레이트를 가용화시킨 연질캅셀제
JPH0215030A (ja) トリアムテレン医薬溶液
KR100359176B1 (ko) 간장질환 예방 및 치료효과를 갖는 2-알릴치오피라진·아스코르빈산염의 조성물 및 그 제조방법
KR960002179B1 (ko) 은행잎 추출물을 함유한 연질캅셀제의 제조방법
BR112020004453A2 (pt) composição para suplementação de cálcio
HK1112672A1 (en) Vinorelbine soft capsule, preparing method and use thereof

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: BRISTOL-MYERS SQUIBB COMPANY